Indicators of Renal Glomerular and Tubular Functions in Patients with Beta-Thalassaemia Major: A cross sectional study at the Royal Hospital, Oman
- PMID: 21509211
- PMCID: PMC3074678
Indicators of Renal Glomerular and Tubular Functions in Patients with Beta-Thalassaemia Major: A cross sectional study at the Royal Hospital, Oman
Abstract
Objectives: There are limited data concerning the assessment of renal function in beta-thalassaemia major, with no study of such involvement in Omani patients. The objective of this study was to establish the pattern of renal glomerular and tubular function using traditional and specific laboratory tests in patients with beta-thalassaemia major.
Methods: This cross-sectional study, from January-July 2008, included 30 patients of the Thalassaemia Clinic at the Royal Hospital, Oman, with transfusion-dependent homozygous beta-thalassaemia major. They included 15 males and 15 females, aged 16-32 years with mean ± standard deviation of 21.23 ± 3.42 years. The medical records were reviewed and renal function states assessed as follows: serum creatinine, estimated glomerular filtration rate (eGFR); urea; phosphate, fractional excretion of filtered sodium (FENa); urine albumin: creatinine index; urine ß2-microglobulin:creatinine index; tubular reabsorption of phosphate (TRP), and tubular maximum phosphate reabsorption (TmP)/GFR.
Results: All patients had eGFR >90 ml/min/1.73m(2); serum creatinine <90 μmol/L; serum urea <6.0 mmol/L, and urine albumin:creatinine <2.5 mg/mmol. Only 2 (6.7%) patients had FENa >1% and 3 (10.0%) patients had urine ß2-microglobulin: creatinine >22 μg/mmol. All patients had TRP >0.85, of whom seven (23.3%) patients had values within the range of 0.85-0.95 and 23 (76.7%) had values >0.95. Also, all patients had TmP/GFR >1.0 mmol/L, of whom only one (3.3%) patient had TmP/GFR of 1.0-1.5, and 29 (96.7%) patients had TmP/GFR >1.5 mmol/L. Finally, 24 (80%) patients had serum phosphate >1.4 mmol/L. Linear regression revealed a highly significant correlation between serum phosphate and TmP/GFR (r = 0.904, P < 0.001).
Conclusion: Renal function, glomerular and tubular, appears to be well preserved in beta-thalassaemia major. Almost all renal function indicators were within the recommended ranges. Raised TmP/GFR and TRP were noted in the majority of patients, reflecting an up-trend in serum phosphate and therefore increasing renal phosphate reabsorption.
Keywords: Beta-thalassaemia; Glomerular; Oman; Renal function; Tubular.
Figures
Similar articles
-
Iron Deficiency and Renal Phosphate Handling: The Role of Maximal Tubular Reabsorption of Phosphate Normalized to Glomerular Filtration Rate (TmP/GFR) in Proximal Tubular Dysfunction.Cureus. 2024 Dec 24;16(12):e76329. doi: 10.7759/cureus.76329. eCollection 2024 Dec. Cureus. 2024. PMID: 39850154 Free PMC article.
-
Assessment of Proximal Tubular Function by Tubular Maximum Phosphate Reabsorption Capacity in Heart Failure.Clin J Am Soc Nephrol. 2022 Feb;17(2):228-239. doi: 10.2215/CJN.03720321. Clin J Am Soc Nephrol. 2022. PMID: 35131929 Free PMC article.
-
Tubular phosphate handling: references from child to adulthood in the era of standardized serum creatinine.Nephrol Dial Transplant. 2022 Oct 19;37(11):2150-2156. doi: 10.1093/ndt/gfab331. Nephrol Dial Transplant. 2022. PMID: 34850142
-
Assessment and interpretation of the tubular threshold for phosphate in infants and children.Pediatr Nephrol. 1994 Apr;8(2):250-1. doi: 10.1007/BF00865491. Pediatr Nephrol. 1994. PMID: 8018507 Review.
-
Reflections on TRP and TP/GFR in the definition of renal phosphate loss: conceptual review.Pediatr Nephrol. 2023 Nov;38(11):3845-3848. doi: 10.1007/s00467-023-05941-x. Epub 2023 Apr 13. Pediatr Nephrol. 2023. PMID: 37052691 Review.
Cited by
-
Glomerular and Tubular Functions in Children and Adults with Transfusion-Dependent Thalassemia.Turk J Haematol. 2018 Mar 1;35(1):66-70. doi: 10.4274/tjh.2017.0266. Epub 2017 Jul 28. Turk J Haematol. 2018. PMID: 28753129 Free PMC article.
-
Biochemical Markers of Early Renal Dysfunction in Patients with β-thalassemia Major: A Systematic Review and Meta-analysis.Curr Med Chem. 2025;32(13):2572-2597. doi: 10.2174/0109298673250805230922054406. Curr Med Chem. 2025. PMID: 37921173
-
Side effects of Deferasirox Iron Chelation in Patients with Beta Thalassemia Major or Intermedia.Oman Med J. 2013 Mar;28(2):121-4. doi: 10.5001/omj.2013.31. Oman Med J. 2013. PMID: 23599881 Free PMC article.
-
Under-recognized Hypoparathyroidism in Thalassemia.J Clin Res Pediatr Endocrinol. 2018 Nov 29;10(4):324-330. doi: 10.4274/jcrpe.0020. Epub 2018 May 4. J Clin Res Pediatr Endocrinol. 2018. PMID: 29726397 Free PMC article.
References
-
- Rajab AG, Patton MA, Modell B. Study of hemoglobinopathies in Oman through a national register. Saudi Med J. 2000;21:1168–72. - PubMed
-
- AlKindi S, Al Zadjali S, Al Madhani A, Daar S, Al Haddabi H, Al Abri Q, et al. Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates. Hemoglobin. 2010;34:135–44. - PubMed
-
- Al-Riyami A, Ebrahim GJ. Genetic blood disorders survey in the Sultanate of Oman. J Trop Pediatr. 2003;49:i1–20. - PubMed
-
- Mohammed AM, Al-Hilli F, Nadkarni KV, Bhagwat GP, Bapat JP. Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in hospital births in Bahrain. Ann Saudi Med. 1992;12:536–9. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous